Patent

Teva UK Ltd and another company v Leo Pharma A/S [2014] EWHC 3096 (Pat), [2014] All ER (D) 54 (Oct)

The defendant company, LEO, owned two pharmaceutical patents. The claimant company, TEVA, sought revocation of both of the patents on the grounds that they were, among other things, obvious. The Chancery Division, Patents Court, held that, given a prior US patent, the two patents were obvious.

If you are not a subscriber, subscribe now to read this content

If you are already a subscriber sign in

...or Register for two weeks' free access to subscriber content

E-newsletter Sign-Up

MOVERS & SHAKERS

Read All

NLJ Career Profile: Nikki Bowker, Devonshires

Nikki Bowker, head of litigation and dispute resolution at Devonshires, on career resilience, diversity in law and channelling Elle Woods when the pressure is on

Ellisons—Sarah Osborne

Leasehold enfranchisement specialist joins residential property team

DWF—Chris Air

Firm strengthens commercial team in Manchester with partner appointment

NEWS

Read All

NLJ this week: ‘Joe Donor’ ruling exposes dangers of unregulated conception

The High Court’s refusal to recognise a prolific sperm donor as a child’s legal parent has highlighted the risks of informal conception arrangements, according to Liam Hurren, associate at Kingsley Napley, in NLJ this week

NLJ this week: CILEX warns Mazur ruling must spark reform

The Court of Appeal’s decision in Mazur may have settled questions around litigation supervision, but the profession should not simply ‘move on’, argues Jennifer Coupland, CEO of CILEX, in this week's NLJ

NLJ this week: Conditional job offers carry hidden risks for employers

A simple phrase like ‘subject to references’ may not protect employers as much as they think. Writing in NLJ this week, Ian Smith, barrister and emeritus professor of employment law at UEA, analyses recent employment cases showing how conditional job offers can still create binding contracts

NLJ this week: Diamond rings and broken promises

An engagement ring may symbolise romance, but the courts remain decidedly practical about who keeps it after a split, writes Mark Pawlowski, barrister and professor emeritus of property law at the University of Greenwich, in this week's NLJ

NLJ this week: The battle over medical report fees intensifies

Medical reporting organisation fees have become ‘the final battleground’ in modern costs litigation, says Kris Kilsby, costs lawyer at Peak Costs and council member of the Association of Costs Lawyers, in this week's NLJ

Error message

Patent

MOVERS & SHAKERS

NLJ Career Profile: Nikki Bowker, Devonshires

Ellisons—Sarah Osborne

DWF—Chris Air